Finepoint Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-735,126	Closed	-$5.82M	–	58
2022 Q2	$5.82M	Buy	+735,126	New	+$5.82M	2.01%	19